“I refuse to believe that journalism means massive privacy violations,” Thiel told the New York Times in May. Thiel’s investments in Silicon Valley are many; at the moment, he is reported to be interested in parabiosis, the process of transfusing the blood of younger people into one’s veins of clients in order to prolong life. Jason Camm, chief medical officer at Thiel Capital, contacted a parabiosis startup called Ambrosia according to a report in Inc last year.
Just call it "Nosferatu" or at least "Spike."